Page results
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
This page explains what a cervical cerclage involves and the risks and benefits of the procedure.
-
This is a speech and language therapy service for deaf or hard of hearing adults who are having communication difficulties because of a hearing loss. The primary focus of the service is to help with spoken English skills.
-
A guide to choosing diabetes technology for UCLH patients
-
Waldenström’s macroglobulinaemia is a rare form of lymphoma (a type of bone marrow cancer), treated at UCLH.
-
This page has been written for patients who are having radiotherapy for bone pain.
-
During winter, the cold weather can put people at higher risk of becoming unwell.
-
Dr Nagendran is a consultant neurophysiologist eripheral nerve and muscle disease, skeletal muscle channelopathies, nerve excitability disorders
-
Our Proton Beam Therapy (PBT) department can treat up to 650 NHS patients per year from across the south of the UK when we are at full capacity. We provide treatment for a wide range of child and teenage cancers and complex adult cancers.
-
This information page has been written to help answer some of the questions you may have about brain metastases, and their treatment with this specialised radiotherapy technique.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer